N4 Pharma Balance Sheet Health
Financial Health criteria checks 6/6
N4 Pharma has a total shareholder equity of £1.3M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £1.3M and £56.0K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£1.20m |
| Equity | UK£1.28m |
| Total liabilities | UK£56.04k |
| Total assets | UK£1.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0GO's short term assets (£1.3M) exceed its short term liabilities (£56.0K).
Long Term Liabilities: 0GO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 0GO is debt free.
Reducing Debt: 0GO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0GO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0GO has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 0.5% each year.